PAA-PVP trial

Not Applicable

Recruiting

• Conditions: Chronic kidney disease undergoing hemodialysis; poly acrylic acid-poly vinylpyrrolidone, hemodialysis, hemostasis

• Registration Number: JPRN-jRCTs032220597
• Lead Sponsor: Yamamoto Suguru

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-31
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients who meet all the inclusion criteria as below,
1. Patients who can obtain written informed consent to participate in this study based on their free will.
2. Patients who are more than 18 years old.
3. Patients undergoing regular hemodialysis treatment 3 times a week and for 3-5 hours each session using internal shunt.
4. Patients who use heparin as anti-coagulant for hemodialysis treatment
5. Patients whose bleeding time after decannulation at the end of hemodialysis treatment is 10 minutes using regular hemostasis pad and band.

Exclusion Criteria

Patients who meet any exclusion criteria as below.
1. Patients who participate in other clinical studies.
2. Patients who are pregnant or want pregnancy.
3. Patients who do not use internal shunt as vascular access.
4. Patients who use fingers or use band for more than 10 minutes for hemostasis after decannulation at the end of hemodialysis treatment.
5. Patients who have serious skin disease.
6. Patients who have the plan to start anti-coagulant/anti-platelet therapy
7. Patients that the investigators decide inappropriate to join the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified